Who is sponsoring NCT04663360?

NCT04663360 is sponsored by Swansea University.

What drugs are being tested in NCT04663360?

Interventions in NCT04663360: Adverse Drug Reaction (ADRe) Profile.

What condition does NCT04663360 study?

NCT04663360 studies Polypharmacy.

Is NCT04663360 still recruiting?

NCT04663360 is currently completed. Last updated 7 October 2021.

Last reviewed 2021-10-07 · How we verify

NCT04663360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medication Monitoring for Older Adults in Primary Care

Completed NA Last updated 7 October 2021

What this trial tests

NA trial testing Adverse Drug Reaction (ADRe) Profile in Polypharmacy in 19 participants. Completed in 4 October 2020.

Timeline

5 January 2020

Primary endpoint
31 May 2020

4 October 2020

Quick facts

Lead sponsor	Swansea University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	19
Start date	5 January 2020
Primary completion	31 May 2020
Estimated completion	4 October 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Adverse Drug Reaction (ADRe) Profile

Conditions studied

Polypharmacy — all drugs for Polypharmacy →

Sponsor

Swansea University

Who can join

64 and older, any sex, with Polypharmacy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polypharmacy has the potential to harm older adults by causing cognitive impairment, falls, and hospitalisations. Many adverse drug reactions could be prevented with closer monitoring. This project will establish the effectiveness of the nurse-led intervention - the ADRe Profile - for medicines commonly prescribed in primary care and evaluate intervention implementation in general practices.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Impact of Implementing a Nurse-Led Adverse Drug Reaction Profile in Older Adults Prescribed Multiple Medicines in UK Primary Care: A Study Protocol for a Cluster-Randomised Controlled Trial.
Logan V, Bamsey A, Carter N, Hughes D, et al · · 2022 · cited 3× · PMID 35645331 · DOI 10.3390/pharmacy10030052
Reducing Adverse Drug Reactions for Older People in the Community: Evaluating the Validity and Reliability of the ADRe Profile.
Logan V, Carter N, Hughes D, Turner A, et al · · 2025 · cited 1× · PMID 40401039 · DOI 10.1155/jonm/9921349
Breaking barriers: feasibility of a cluster randomised trial evaluating an instrument for identifying and ameliorating adverse drug reactions.
Logan V, Hughes D, Turner A, Carter N, et al · · 2026 · PMID 41592836 · DOI 10.1136/bmjopen-2025-099627

Verify or expand the search:

Other recruiting trials for Polypharmacy

Currently open trials in the same condition.

NCT06110156 — Population Health Approach to Optimizing Medications in Older Adults · NA · active not recruiting
NCT07022990 — Improving Medication Management in World Trade Center Responders · NA · recruiting
NCT06451692 — Prioritising Patient Medication Review: Hospitals Reaching Out · NA · recruiting
NCT05526963 — Reduction of Polypharmacy in Elderly People With Multiple Diseases · NA · recruiting
NCT06273761 — Evaluation of Medication Management Service · NA · recruiting

Other Swansea University trials

Trials by the same sponsor.

NCT07452562 — Hesperidin RCT in MS · NA · recruiting
NCT07272096 — ACTing Minds: An ACT-based Videogame for Mental Health · NA · completed
NCT06961513 — Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction. · not yet recruiting
NCT06698588 — Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms · NA · recruiting
NCT06407557 — Optimizing Older Adults' Home Space for Physical Activity · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04663360 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swansea University
Last refreshed: 7 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing